ADC THERAPEUTICS SA shareholders Q3 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.

ADC THERAPEUTICS SA shareholders Q3 2023
NameSharesValueWeighting ↓
ACADIAN ASSET MANAGEMENT LLC 156,048$1380.00%
MARSHALL WACE, LLP 438,673$394,8060.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,232$2,0020.00%
EVERGREEN CAPITAL MANAGEMENT LLC 11,000$9,8670.00%
GOLDMAN SACHS GROUP INC 1,052,978$944,5210.00%
MORGAN STANLEY 664,027$595,6320.00%
ROYAL BANK OF CANADA 8,085$8,0000.00%
BlackRock Inc. 529,890$475,3110.00%
Citadel Advisors 2,200$1,9730.00%
Citadel Advisors 5,400$4,8440.00%
Cutler Group LLC / CA 1,400$10.00%
SIMPLEX TRADING, LLC 1,232$10.00%
Qube Research & Technologies Ltd 207$1860.00%
Tower Research Capital LLC (TRC) 4,120$3,6960.00%
MONETA GROUP INVESTMENT ADVISORS LLC 19,496$17,4880.00%
Cornerstone Planning Group LLC 14$130.00%
Focused Wealth Management, Inc 300$2690.00%
OSAIC HOLDINGS, INC. 22,629$20,2970.00%
FMR LLC 1,315$1,1790.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q3 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.